Limsophy LIMS Verified listing

Limsophy LIMS Verified listing

Indicaton

Laboratory Software

Therapeutic indications

Diagnostic

Type of product

Table

Phase

Marketed
Available in

Switzerland, Germany, Austria, France, Italy, EU, Brasil, South-Africa

You may also be interested in

Proclarix

Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.

Marketed

Small molecule therapeutic that aims to treat Alzheimer’s patients

Alzheimer’s disease

Discovery

Breast cancer screening test

Xemperia flag-ship project is a PCR-based blood test for breast cancer screening.
The technology can be adapted to other cancers, immune, inflammatory and cardiovascular diseases.
Xemperia's pipeline also includes DNA based nansensors for the ultrasensitive detection of nucleic acids.

Phase II completed